TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01969123

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

Cause of deathRegulatory or ethics Automatic label, confidence 0.9, unverified. How labels are made.
“Study has been suspended due to clinical hold.”

The sponsor’s own words in the registry.

Life of this trial

201320142015201620172018Started2013-10Registered2013-10-21Stopped2017-01

Vital statistics

Status
Terminated
Phase
Phase 3
Sponsor
FORUM Pharmaceuticals Inc
Sponsor type
Industry
Conditions
Alzheimer's Disease; Dementia
Interventions
Drug: EVP-6124; Placebo
Participants
474
Sites
82
Countries
Australia, Belgium, Canada, France, Germany, Italy, Mexico, Poland, South Africa, South Korea, Spain, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.